ClinicalTrials.govpublic full text
A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma
metastatic melanoma and merkel cell carcinoma, melanoma, merkel cell carcinoma, metastatic skin cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 867320
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.